Category: PharmaceuticalsSyndicate content

Allergan pushes to kick Valeant, Pershing out of special shareholder meeting

September 16, 2014 by Arezu Sarvestani

Allergan is still looking to prevent Valeant Pharmaceuticals and Pershing Square from voting their shares in a December 18 shareholder meeting the company was forced to host.

Allergan cedes to shareholder meeting, but still pushes for injunction

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

TCT 2014 Roundup

September 15, 2014 by Brad Perriello

A roundup of studies released at the annual Transcatheter Cardiovascular Therapies conference in Washington this week.

TCT 2014 Roundup

Here's a look at some of the news coming out of Washington at the 26th annual Transcatheter Cardiovascular Therapies conference this week:

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxter names its pharma spinout: Baxalta

September 11, 2014 by Arezu Sarvestani

Baxter's has 'high' hopes for its coming Baxalta spinout, which will get a full visual work-up before the company goes live mid-2015.

Baxter names its pharma spinout: Baxalta

Baxter (NYSE:BAX) crept a little closer to spinning out its biopharmaceuticals division into an independent entity by giving the company a name: Baxalta.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Allergan caves to shareholder meeting after Valeant, Ackman rally support

September 9, 2014 by Arezu Sarvestani

Allergan confirmed late last week that it would call the shareholder meeting demanded by unsolicited buyers Valeant Pharmaceuticals and activist investor William Ackman.

Allergan caves to shareholder meeting after Valeant, Ackman rally support

Valeant sues Allergan for special meeting after show of shareholder support

August 25, 2014 by Arezu Sarvestani

Valeant Pharmaceuticals files a lawsuit aiming to force Allergan to hold a special shareholder meeting after hand-delivering 1,500 pages of documents showing shareholder support.

Valeant files new lawsuit in Allergan acquisition saga

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Allergan can't delay shareholder vote on hostile Valeant bid

August 22, 2014 by Brad Perriello

Valeant Pharmaceuticals and Pershing Square Capital Management reportedly plan to ask Allergan for a shareholder vote on their hostile takeover attempt, after a federal judge rules that Allergan's insider trading lawsuit won't delay the meeting.

Allergan can't delay shareholder vote on hostile Valeant bid

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp